Global University Venturing

Florida State University cornea repair drug developer Trefoil Therapeutics added funding from investors including subsidiaries of Aju Corporation and Access Biotechnology to bring its total to $33.2m.

Research Bridge’s new seed fund will back spinouts in the central US states in a move intended to plug the dearth of venture capital availability compared with clusters on the west and east coasts.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Boehringer Ingelheim will pay a total of up to $365m to acquire its venture fund's portfolio company Amal Therapeutics, an immunotherapy spinout of University of Geneva.

The series C for Utah-founded drug discovery platform creator Recursion included capital from University of Minnesota and Texas Tech University System.

Viraj Perera has joined University of South Australia's commercialisation arm as CEO after five years leading Platcom Ventures for National Innovation Agency of Malaysia.

Endless Frontier Labs will operate as a nine-month accelerator initiative set up in place of the defunct CDL-NYC partnership with University of Toronto.

ICL and Royal College of Art-founded edtech developer Sam Labs has now raised $19.8m in all to sustain the growth of its coding education kit business.

Entrepreneurs Fund’s EF Investments and Bayern Kapital contributed to a round that increased Würzburg-founded traumatic brain injury drug developer Vasopharm’s total to above $57.8m.

Parkwalk Advisors has led a funding round for University of Cambridge's graphene technology business Paragraf, which will use the money to increase its headcount.

Cancer treatment company Biontech raised $325m round backed by Fidelity. The company forms part of the hopeful oncology and cancer treatment subsector of life sciences which has seen much growth and in corporate backing in recent years.